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1. Introduction 
The NADH dehydrogenase content of mitochondria 
and submitochondrial particles is more difficult to 
measure than the content of other electron-transport 
complexes. The absence of unambiguously identifi- 
able chromophores has, until recently, necessitated 
the use of more indirect measurements based on turn- 
over numbers. For example, a turnover number of 
8 X 10’. mm-‘. mol FMN-’ in the NADH-KsFe(CN), 
oxidoreductase assay was determined [l] for the 
soluble type 1 NADH dehydrogenase. From this value 
and the specific activity of NADH-KaFe(CN), 
oxidoreductase in submitochondrial particles, a value 
for the NADH dehydrogenase content of the latter 
was calculated (0.03 nmol/mg protein). That this 
value (as nmol dehydrogenase FMN/mg protein) was 
considerably less than the total acidextractable FMN 
content of these particles showed that the use of total 
FMN content was an unreliable way of estimating 
NADH dehydrogenase content. 
However, the turnover numbers of purified NADH 
dehydrogenase preparations, all containing similar 
concentrations of FMN, vary considerably with the 
purification procedure between 4 X 10’ for complex I 
and 1.5 X lo6 for the preparation of [2]. In the 
absence of clear evidence that the lower range repre- 
sents inactivation, dehydrogenase contents based on 
NADH-KsFe(CN)6 oxidoreductase activities should 
be treated with reservation. NADH-ubiquinone 
oxidoreductase activity is probably also unreliable in 
this respect since the kinetics of this reaction are very 
dependent on the phospholipid environment [3]. 
Here we describe two assays of NADH dehydrog- 
enase content using antibodies to purified complex I. 
From these values we calculate the true turnover 
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number of the enzyme in the membrane and show 
that previous estimates of the NADH dehydrogenase 
content of submitochondrial particles require revision. 
2. Materials and methods 
Submitochondrial particles (SMP) and complex I 
from bovine heart were prepared by the methods in 
[4,5], respectively. Antibodies to complex I were 
raised in rabbits as in [6] and their ability to immuno- 
precipitate NADH dehydrogenase from detergent- 
solubilised SMP was tested as in [7]. Fluorimetric 
analysis of non-covalently bound FMN and FAD was 
carried out as in [8]. FMN and FAD standards were 
purified from commercial FMN and FAD by DEAE- 
cellulose chromatography [9]. Fluorescence was mea- 
sured in a Perkin Elmer MPF-44A fluorescence spectro- 
photometer with excitation at 450 nm and emission 
at 520 nm. Rocket electrophoresis was carried out as 
in [lo] except that protein samples were solubilised 
in Triton X-100 (l%, w/v) and Na-deoxycholate 
(2.5 mg/mg protein) instead of Triton and SDS. 
NADH-KsFe(CN), oxidoreductase activity was 
measured at 30°C exactly as in [ 1 l] for the so-called 
‘30°C enzyme’. Protein was measured as in [ 121 using 
bovine serum albumin (Sigma fraction V) as a standard. 
3. Results and discussion 
In the experiment of table 1, non-covalently bound 
flavin was released from protein by boiling [8] and 
its fluorescence at neutral pH compared with an FMN 
standard. Thus the value of 0.157 nmol/mg protein 
for SMP contains contributions from both FMN and 
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Table 1 
Estimation of NADH dehydrogenase FMN by fluorescence 
Sample and treatment Fluorescence 
(arbitrary units) 
Flavin content 
(nmol/mg protein) 
Complex I (23.3 pg protein) 88 0.80 
Complex I + antiserum (total) 132 
Complex I + antiserum (sup.) 50 
Immunoprecipitate (by diff.) 82 0.75 
SMP-1 (267 pg protein) 158 (0.157) 
SMP + antiserum (total) 206 
SMP + antiserum (sup.) 140 
Immunoprecipitate (by diff.) 66 0.066 
Complex I (58.2 I.rg protein) was incubated in 2.5 ml final vol. of 0.67 M sucrose/ 
50 mM Tris-HCl (pH 8.0) for 2 h at 0°C. Where indicated, 2 ml anti-(complex I) 
serum and 0.14 ml 20% (w/v) Triton X-100 replaced part of the sucrose-Tris 
buffer. Flavin was released by heating to 100°C for 3 min in the dark. Another 
sample containing antiserum and Triton was centrifuged at 50 000 X g for 15 min, 
and the supernatant was heated as above. Portions of SMP (668 fig protein) were 
treated identically. The heated samples were cooled, centrifuged at 100 000 X g 
for 15 min and filtered to remove traces of insoluble material. The fluorescence of 
1 ml portions diluted with 1 ml sucrose-Tris buffer was compared with that of 
FMN (O-100 pmol) in 2 ml same buffer 
February 1980 
FAD. The fluorescence of the sample from SMP 
which had been treated with Triton X-100 and suffi- 
cient antiserum to completely agglutinate the NADH 
dehydrogenase present was higher than that of SMP 
alone. This increase was due to traces of fluorescent 
material in both the Triton and the antiserum. After 
removal of the immunoprecipitate by centrifugation, 
the fluorescence released from the supernatant by 
boiling was decreased. This decrease in fluorescence 
represents the loss of the FMN-containing NADH 
dehydrogenase and therefore can be directly converted 
into nmol FMN without consideration of the FAD 
originally present. Thus, the NADH dehydrogenase 
content of the SMP was found to be 0.066 nmol 
enzyme-bound FMN/mg protein. The total non- 
covalently bound FMN and FAD contents of these 
SMP were 0.133 and 0.246 nmol/mg protein, respec- 
tively. A second SMP preparation (SMP-2) was found 
to have an NADH dehydrogenase content of 0.075 
nmol/mg protein. 
The validity of this experimental approach is 
shown by the results of table 1 obtained with com- 
plex I. The immunoprecipitatable flavin was almost 
exactly the same as the total flavin, as would be 
expected. Thus, the fluorescent impurities introduced 
with the Triton and antiserum did not interfere with 
the assay. The only other source of error would be 
if the antiserum was not specific for complex I. We 
have analyzed immunoprecipitates by one and two 
dimensional gel electrophoresis [6] to establish their 
purity. However, the assay of table 1 requires only 
that the antiserum should not precipitate any other 
flavoproteins. 
A direct estimate of the NADH dehydrogenase 
content as a % of mitochondrial or SMP protein was 
obtained by rocket immunoelectrophoresis (fig.1). 
Rocket area rather than height gave the more linear 
relationship with antigen concentration. The com- 
plex I content of heavy layer mitochondria was found 
to be 4.8% based on protein (0.036 nmol/mg) while 
SMP-1 and SMP-2 contained 9.3% (0.070 nmol/mg) 
and 8.5% complex I (0.064 nmol/mg). The values for 
SMP are in good agreement with those obtained from 
fluorescence measurements. On the whole, the repro- 
ducibility of the rocket assay with crude membrane 
preparations is not as good as the fluorescence assay. 
Factors contributing to this include non-specific 
precipitation of membrane proteins leading to distor- 
tion of the rocket, and fragmentation of NADH dehy- 
drogenase during electrophoresis. 
Table 2 summarizes pecific activities and turnover 
numbers based on the dehydrogenase content. The 
addition of Triton X-100 and antiserum to SMP did 
not alter the V,, of NADH-KaFe(CN), oxidoreduc- 
Volume 110, number 2 FEBS LETTERS February 1980 
Fig.1. Rocket immunoelectrophoresis of complex I and submitochondrial particles. Immunoelectrophoresis was carried out in 
1% (w/v) agarose gels containing 30 mM Tris-glycine (pH 8.6) 1% (w/v) Triton X-100 and 43 ~1 anti-(complex I) serum/ml gel. 
Complex I was diluted to 2 mg protein/ml Tris-glycine buffer containing 1% (w/v) Triton X-100 and 0.4 mg Na deoxycholate/mg 
protein. SMP-1 were diluted to 10 mg/ml with the same buffer and dissolved with Triton X-100 and deoxycholate as above. The 
amount of protein (in clg) applied to each well is shown. Electrophoresis was at 2.5 V/cm for 24 h at 4’C. 
tase activity. Some activity was not precipitated by 
antiserum [7], and could be distinguished from resi- 
dual NADH dehydrogenase by its very much lower Km. 
Thus, under the assay conditions used, this activity 
did not vary with KsFe(CIQ concentration and 
amounted to 0.75 and 0.82 pmol NADH . min-' . mg 
SMP-1 and SMP-2-r protein-‘, respectively. Correc- 
tion of the total activities for this residual activity 
caused a small increase in both the Km for KaFe(CN), 
and the V,, as indicated in table 2. Turnover numbers 
based on the corrected activities were 4.6 X 105/min 
for SMP-1 and 4.5 X 105/min for SMP-2. Since all 
complex I activity is precipitated by antiserum [ 131, 
no correction to the I’,, was required and a very 
Table 2 
Turnover numbers of NADH dehydrogenase 
Prep. NADH dehydrogenase 
FMN (nmol/mg protein) 
NADH-K,Fe(CN), oxidoreductase 
Before correction After correction 
V max &mol NADH/ Km V max hmol NADH/ Km Turnover no. 
min/mg protein (mM) min/mg protein) (mM) (per min) 
SMP-1 0.066 
SMP-2 0.075 
Complex I 0.75 
30 2.8 31 3.3 4.6 x lo5 
33 2.7 34 2.8 4.5 x lo5 
330 2.2 - _ 4.4 x lo5 
NADH-K,Fe(CN), oxidoreductase activities were measured at different K,Fe(CN), concentrations [11) to determine Vmax and 
Km for K,Fe(CN),. SMP were pretreated with Triton X-100 and antiserum as in table 1. Activities were measured before and 
after centrifugation so that correction could be made for the activity catalyzed by enzyme(s) other than NADH dehydrogenase 
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similar turnover number of 4.4 X lO’/min was 
obtained. Thus, there is a strict parallel between zyme- 
bound FMN and NADH-KsFe(CN), oxidoreductase 
activity during purification of complex I. 
This is not true, however, of other NADH dehy- 
drogenase preparations such as those in: [I] (turnover 
no. 8 X 105/min); [ 141 (turnover no. 1 .S X 106/min); 
[IS] (turnover no. 7.4 X IO’fmin); [2] (turnover 
no. 1.5 X 106/min). Clearly these preparations are 
activated uring purification. The use of high turnover 
numbers to calculate the NADH dehydrogenase con- 
tent of SMP obviously produces values which are too 
low. in view of this it will be necessary to reassess the 
conclusion that membrane-bound NADH dehy- 
drogenase binds 2 molecules inhibitor piericidin/mole- 
cule enzyme [ 161. Since the piericidin titre was 
reported to be 0.05-0.06 nmoljmg SMP protein 
[ 16,171 it is possible that the stoichiometry is only 
1: 1. The halving of the piericidin titre by mersalyl 
[ 161 will then require an alternative xplanation 
perhaps based on a multimeric NADH dehydrogenase 
(e.g. [W. 
Further corroboration of these fmdings has been 
provided ([ 181, Albracht et al. personal communication) 
by determining the relative stoichiometry of the iron- 
sulphur centres of NADH dehydrogenase in SMP. The 
molar ratio f centre 2 to cytochrome cl in SMP was 
found to be 0.28: 1. Assuming a typical cytochrome c1 
content of 0.25 nmol/mg protein this leads to an 
estimated centre 2 (or dehydrogenase) content of 
0.070 nmol~mg protein in good agreement with the 
values we have obtained. 
Lastly, we wish to point out that the preparation 
of complex I used for FMN and activity measurements 
in these studies was rather impure, and more realistic 
figures for the dehydrogenase content of SMP and 
mitochondria would be -6% and 3%, respectively, In 
view of this, the yield of complex I from mitochon- 
dria (1 .I -1.8% [S]) represents a more respectable 
recovery than was suspected and further suggests hat 
NADH-ubiquinone oxidoreductase activity [S] is 
lost to some extent during purification. 
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